Loading...

Anil Tulpule, MD

Title(s)Associate Professor of Clinical Medicine
Phone+1 323 865 3927
vCardDownload vCard

    Collapse Overview 
    Collapse Overview
    Dr. Tulpule began his medical education and career in his native India before coming to Southern California on a fellowship in medical oncology at the Keck School of Medicine. After completion of his first USC fellowship, Dr. Tulpule was granted an additional fellowship in the Department of Hematology where he is currently holds an assistant professor appointment. Dr. Tulpule remains active in AIDS research, including a ten year affiliation with the government sponsored AIDS-Related Malignancy Working Group at the National Cancer Institute.

    He has received over fifteen research grants on a number of hematology related subjects and his work has been published in many noted medical journals. Dr. Tulpule is a member of the LAC+USC Medical Center’s Internal Review Board and has a role in determining the ethical implications of the center’s research studies. His dedication to ethical practices also includes a membership of USC Norris Comprehensive Cancer Center’s Patient’s Rights Committee.

    Collapse ORNG Applications 
    Collapse Websites

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Lansigan F, Horwitz SM, Pinter-Brown LC, Rosen ST, Pro B, Hsi ED, Federico M, Gisselbrecht C, Schwartz M, Bellm LA, Acosta M, Shustov AR, Advani RH, Feldman T, Lechowicz MJ, Smith SM, Tulpule A, Craig MD, Greer JP, Kahl BS, Leach JW, Morganstein N, Casulo C, Park SI, Foss FM. Outcomes for Relapsed and Refractory Peripheral T-Cell Lymphoma Patients after Front-Line Therapy from the COMPLETE Registry. Acta Haematol. 2019 Jul 17; 1-11. PMID: 31315113.
      View in: PubMed
    2. Park SI, Horwitz SM, Foss FM, Pinter-Brown LC, Carson KR, Rosen ST, Pro B, Hsi ED, Federico M, Gisselbrecht C, Schwartz M, Bellm LA, Acosta M, Advani RH, Feldman T, Lechowicz MJ, Smith SM, Lansigan F, Tulpule A, Craig MD, Greer JP, Kahl BS, Leach JW, Morganstein N, Casulo C, Shustov AR. The role of autologous stem cell transplantation in patients with nodal peripheral T-cell lymphomas in first complete remission: Report from COMPLETE, a prospective, multicenter cohort study. Cancer. 2019 May 01; 125(9):1507-1517. PMID: 30694529.
      View in: PubMed
    3. Hermel DJ, Chiu V, Hermel MH, Tulpule A, Akhtari M. Cardiac birth defects in a twin infant born to a woman with chronic myeloid leukemia on dasatinib. J Oncol Pharm Pract. 2019 Apr; 25(3):699-702. PMID: 29207935.
      View in: PubMed
    4. Leonard JP, Kolibaba KS, Reeves JA, Tulpule A, Flinn IW, Kolevska T, Robles R, Flowers CR, Collins R, DiBella NJ, Papish SW, Venugopal P, Horodner A, Tabatabai A, Hajdenberg J, Park J, Neuwirth R, Mulligan G, Suryanarayan K, Esseltine DL, de Vos S. Randomized Phase II Study of R-CHOP With or Without Bortezomib in Previously Untreated Patients With Non-Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma. J Clin Oncol. 2017 Nov 01; 35(31):3538-3546. PMID: 28862883.
      View in: PubMed
    5. Hsi ED, Horwitz SM, Carson KR, Pinter-Brown LC, Rosen ST, Pro B, Federico M, Gisselbrecht C, Schwartz M, Bellm LA, Acosta M, Collie AM, Gruver AM, Grzywacz BJ, Turakhia S, Shustov AR, Advani RH, Feldman T, Lechowicz MJ, Smith SM, Lansigan F, Tulpule A, Craig MD, Greer JP, Kahl BS, Leach JW, Morganstein N, Casulo C, Park SI, Foss FM. Analysis of Peripheral T-cell Lymphoma Diagnostic Workup in the United States. Clin Lymphoma Myeloma Leuk. 2017 04; 17(4):193-200. PMID: 28209473.
      View in: PubMed
    6. Carson KR, Horwitz SM, Pinter-Brown LC, Rosen ST, Pro B, Hsi ED, Federico M, Gisselbrecht C, Schwartz M, Bellm LA, Acosta MA, Shustov AR, Advani RH, Feldman TA, Lechowicz MJ, Smith SM, Lansigan F, Tulpule A, Craig MD, Greer JP, Kahl BS, Leach JW, Morganstein N, Casulo C, Park SI, Foss FM. A prospective cohort study of patients with peripheral T-cell lymphoma in the United States. Cancer. 2017 Apr 01; 123(7):1174-1183. PMID: 27911989.
      View in: PubMed
    7. Xie Y, Bulbul MA, Ji L, Inouye CM, Groshen SG, Tulpule A, O'Malley DP, Wang E, Siddiqi IN. p53 expression is a strong marker of inferior survival in de novo diffuse large B-cell lymphoma and may have enhanced negative effect with MYC coexpression: a single institutional clinicopathologic study. Am J Clin Pathol. 2014 Apr; 141(4):593-604. PMID: 24619762.
      View in: PubMed
    8. Levine AM, Noy A, Lee JY, Tam W, Ramos JC, Henry DH, Parekh S, Reid EG, Mitsuyasu R, Cooley T, Dezube BJ, Ratner L, Cesarman E, Tulpule A. Pegylated liposomal doxorubicin, rituximab, cyclophosphamide, vincristine, and prednisone in AIDS-related lymphoma: AIDS Malignancy Consortium Study 047. J Clin Oncol. 2013 Jan 01; 31(1):58-64. PMID: 23169503.
      View in: PubMed
    9. Wilson WH, O'Connor OA, Czuczman MS, LaCasce AS, Gerecitano JF, Leonard JP, Tulpule A, Dunleavy K, Xiong H, Chiu YL, Cui Y, Busman T, Elmore SW, Rosenberg SH, Krivoshik AP, Enschede SH, Humerickhouse RA. Navitoclax, a targeted high-affinity inhibitor of BCL-2, in lymphoid malignancies: a phase 1 dose-escalation study of safety, pharmacokinetics, pharmacodynamics, and antitumour activity. Lancet Oncol. 2010 Dec; 11(12):1149-59. PMID: 21094089.
      View in: PubMed
    10. Cianfrocca M, Lee S, Von Roenn J, Tulpule A, Dezube BJ, Aboulafia DM, Ambinder RF, Lee JY, Krown SE, Sparano JA. Randomized trial of paclitaxel versus pegylated liposomal doxorubicin for advanced human immunodeficiency virus-associated Kaposi sarcoma: evidence of symptom palliation from chemotherapy. Cancer. 2010 Aug 15; 116(16):3969-77. PMID: 20564162.
      View in: PubMed
    11. Liu R, Gong M, Li X, Zhou Y, Gao W, Tulpule A, Chaudhary PM, Jung J, Gill PS. Induction, regulation, and biologic function of Axl receptor tyrosine kinase in Kaposi sarcoma. Blood. 2010 Jul 15; 116(2):297-305. PMID: 20442363.
      View in: PubMed
    12. Liu R, Li X, Tulpule A, Zhou Y, Scehnet JS, Zhang S, Lee JS, Chaudhary PM, Jung J, Gill PS. KSHV-induced notch components render endothelial and mural cell characteristics and cell survival. Blood. 2010 Jan 28; 115(4):887-95. PMID: 19965636.
      View in: PubMed
    13. Masiello D, Tulpule A. Bendamustine therapy in chronic lymphocytic leukemia. Expert Opin Pharmacother. 2009 Jul; 10(10):1687-98. PMID: 19527193.
      View in: PubMed
    14. Robinson KS, Williams ME, van der Jagt RH, Cohen P, Herst JA, Tulpule A, Schwartzberg LS, Lemieux B, Cheson BD. Phase II multicenter study of bendamustine plus rituximab in patients with relapsed indolent B-cell and mantle cell non-Hodgkin's lymphoma. J Clin Oncol. 2008 Sep 20; 26(27):4473-9. PMID: 18626004.
      View in: PubMed
    15. Straus DJ, Testa MA, Sarokhan BJ, Czuczman MS, Tulpule A, Turner RR, Riggs SA. Quality-of-life and health benefits of early treatment of mild anemia: a randomized trial of epoetin alfa in patients receiving chemotherapy for hematologic malignancies. Cancer. 2006 Oct 15; 107(8):1909-17. PMID: 16977654.
      View in: PubMed
    16. Tulpule A, Espina BM, Berman N, Buchanan LH, Smith DL, Sherrod A, Dharmapala D, Gee C, Boswell WD, Nathwani BN, Welles L, Levine AM. Phase I/II trial of nonpegylated liposomal doxorubicin, cyclophosphamide, vincristine, and prednisone in the treatment of newly diagnosed aggressive non-Hodgkin's lymphoma. Clin Lymphoma Myeloma. 2006 Jul; 7(1):59-64. PMID: 16879771.
      View in: PubMed
    17. Levine AM, Tulpule A, Quinn DI, Gorospe G, Smith DL, Hornor L, Boswell WD, Espina BM, Groshen SG, Masood R, Gill PS. Phase I study of antisense oligonucleotide against vascular endothelial growth factor: decrease in plasma vascular endothelial growth factor with potential clinical efficacy. J Clin Oncol. 2006 Apr 10; 24(11):1712-9. PMID: 16520466.
      View in: PubMed
    18. Lim ST, Karim R, Tulpule A, Nathwani BN, Levine AM. Prognostic factors in HIV-related diffuse large-cell lymphoma: before versus after highly active antiretroviral therapy. J Clin Oncol. 2005 Nov 20; 23(33):8477-82. PMID: 16230675.
      View in: PubMed
    19. Tulpule A. Multidrug resistance in AIDS-related lymphoma. Curr Opin Oncol. 2005 Sep; 17(5):466-8. PMID: 16093797.
      View in: PubMed
    20. Lim ST, Karim R, Nathwani BN, Tulpule A, Espina B, Levine AM. AIDS-related Burkitt's lymphoma versus diffuse large-cell lymphoma in the pre-highly active antiretroviral therapy (HAART) and HAART eras: significant differences in survival with standard chemotherapy. J Clin Oncol. 2005 Jul 01; 23(19):4430-8. PMID: 15883411.
      View in: PubMed
    21. Noy A, Scadden DT, Lee J, Dezube BJ, Aboulafia D, Tulpule A, Walmsley S, Gill P. Angiogenesis inhibitor IM862 is ineffective against AIDS-Kaposi's sarcoma in a phase III trial, but demonstrates sustained, potent effect of highly active antiretroviral therapy: from the AIDS Malignancy Consortium and IM862 Study Team. J Clin Oncol. 2005 Feb 10; 23(5):990-8. PMID: 15598977.
      View in: PubMed
    22. Masood R, Xia G, Smith DL, Scalia P, Still JG, Tulpule A, Gill PS. Ephrin B2 expression in Kaposi sarcoma is induced by human herpesvirus type 8: phenotype switch from venous to arterial endothelium. Blood. 2005 Feb 01; 105(3):1310-8. PMID: 15471957.
      View in: PubMed
    23. Levine AM, Tulpule A, Espina B, Sherrod A, Boswell WD, Lieberman RD, Nathwani BN, Welles L. Liposome-encapsulated doxorubicin in combination with standard agents (cyclophosphamide, vincristine, prednisone) in patients with newly diagnosed AIDS-related non-Hodgkin's lymphoma: results of therapy and correlates of response. J Clin Oncol. 2004 Jul 01; 22(13):2662-70. PMID: 15226333.
      View in: PubMed
    24. Tulpule A, Espina BM, Pedro Santabarbara AB, Palmer M, Schiflett J, Boswell W, Smith S, Levine AM. Treatment of AIDS related non-Hodgkin's lymphoma with combination mitoguazone dihydrochloride and low dose CHOP chemotherapy: results of a phase II study. Invest New Drugs. 2004 Jan; 22(1):63-8. PMID: 14707495.
      View in: PubMed
    25. Tulpule A, Groopman J, Saville MW, Harrington W, Friedman-Kien A, Espina BM, Garces C, Mantelle L, Mettinger K, Scadden DT, Gill PS. Multicenter trial of low-dose paclitaxel in patients with advanced AIDS-related Kaposi sarcoma. Cancer. 2002 Jul 01; 95(1):147-54. PMID: 12115328.
      View in: PubMed
    26. Levine AM, Sadeghi S, Espina B, Tulpule A, Nathwani B. Characteristics of indolent non-Hodgkin lymphoma in patients with type 1 human immunodeficiency virus infection. Cancer. 2002 Mar 01; 94(5):1500-6. PMID: 11920507.
      View in: PubMed
    27. Tulpule A, Sherrod A, Dharmapala D, Young LL, Espina BM, Sanchez MN, Gill PS, Levine AM. Multidrug resistance (MDR-1) expression in AIDS-related lymphomas. Leuk Res. 2002 Feb; 26(2):121-7. PMID: 11755462.
      View in: PubMed
    28. Bi J, Espina BM, Tulpule A, Boswell W, Levine AM. High-dose cytosine-arabinoside and cisplatin regimens as salvage therapy for refractory or relapsed AIDS-related non-Hodgkin's lymphoma. J Acquir Immune Defic Syndr. 2001 Dec 15; 28(5):416-21. PMID: 11744828.
      View in: PubMed
    29. Masood R, Cai J, Tulpule A, Zheng T, Hamilton A, Sharma S, Espina BM, Smith DL, Gill PS. Interleukin 8 is an autocrine growth factor and a surrogate marker for Kaposi's sarcoma. Clin Cancer Res. 2001 Sep; 7(9):2693-702. PMID: 11555581.
      View in: PubMed
    30. Levine AM, Tulpule A. Clinical aspects and management of AIDS-related Kaposi's sarcoma. Eur J Cancer. 2001 Jul; 37(10):1288-95. PMID: 11423260.
      View in: PubMed
    31. Levine AM, Seneviratne L, Tulpule A. Incidence and management of AIDS-related lymphoma. Oncology (Williston Park). 2001 May; 15(5):629-39; discussion 639-40, 645-6. PMID: 11396357.
      View in: PubMed
    32. Tulpule A, Rarick MU, Kolitz J, Bernstein J, Myers A, Buchanan LA, Espina BM, Traynor A, Letzer J, Justice GR, McDonald D, Roberts L, Boswell W, Nathwani B, Levine AM. Liposomal daunorubicin in the treatment of relapsed or refractory non-Hodgkin's lymphoma. Ann Oncol. 2001 Apr; 12(4):457-62. PMID: 11398876.
      View in: PubMed
    33. Levine AM, Seneviratne L, Espina BM, Wohl AR, Tulpule A, Nathwani BN, Gill PS. Evolving characteristics of AIDS-related lymphoma. Blood. 2000 Dec 15; 96(13):4084-90. PMID: 11110677.
      View in: PubMed
    34. Masood R, Nagpal S, Zheng T, Cai J, Tulpule A, Smith DL, Gill PS. Kaposi sarcoma is a therapeutic target for vitamin D(3) receptor agonist. Blood. 2000 Nov 01; 96(9):3188-94. PMID: 11050002.
      View in: PubMed
    35. Levine AM, Li P, Cheung T, Tulpule A, Von Roenn J, Nathwani BN, Ratner L. Chemotherapy consisting of doxorubicin, bleomycin, vinblastine, and dacarbazine with granulocyte-colony-stimulating factor in HIV-infected patients with newly diagnosed Hodgkin's disease: a prospective, multi-institutional AIDS clinical trials group study (ACTG 149). J Acquir Immune Defic Syndr. 2000 Aug 15; 24(5):444-50. PMID: 11035615.
      View in: PubMed
    36. Tulpule A, Scadden DT, Espina BM, Cabriales S, Howard W, Shea K, Gill PS. Results of a randomized study of IM862 nasal solution in the treatment of AIDS-related Kaposi's sarcoma. J Clin Oncol. 2000 Feb; 18(4):716-23. PMID: 10673512.
      View in: PubMed
    37. Tulpule A, Levine A. AIDS-related lymphoma. Blood Rev. 1999 Sep; 13(3):147-50. PMID: 10527266.
      View in: PubMed
    38. Gill PS, Tulpule A, Espina BM, Cabriales S, Bresnahan J, Ilaw M, Louie S, Gustafson NF, Brown MA, Orcutt C, Winograd B, Scadden DT. Paclitaxel is safe and effective in the treatment of advanced AIDS-related Kaposi's sarcoma. J Clin Oncol. 1999 Jun; 17(6):1876-83. PMID: 10561228.
      View in: PubMed
    39. Tulpule A, Schiller G, Harvey-Buchanan LA, Lee M, Espina BM, Khan AU, Boswell W, Nathwani B, Levine AM. Cladribine in the treatment of advanced relapsed or refractory low and intermediate grade non-Hodgkin's lymphoma. Cancer. 1998 Dec 01; 83(11):2370-6. PMID: 9840537.
      View in: PubMed
    40. Tulpule A, Yung RC, Wernz J, Espina BM, Myers A, Scadden DT, Cabriales S, Ilaw M, Boswell W, Gill PS. Phase II trial of liposomal daunorubicin in the treatment of AIDS-related pulmonary Kaposi's sarcoma. J Clin Oncol. 1998 Oct; 16(10):3369-74. PMID: 9779714.
      View in: PubMed
    41. McGarvey ME, Tulpule A, Cai J, Zheng T, Masood R, Espina B, Arora N, Smith DL, Gill PS. Emerging treatments for epidemic (AIDS-related) Kaposi's sarcoma. Curr Opin Oncol. 1998 Sep; 10(5):413-21. PMID: 9800111.
      View in: PubMed
    42. Tulpule A, Matheny SC. AIDS-Related malignancies. Prim Care. 1998 Jun; 25(2):473-82. PMID: 9628964.
      View in: PubMed
    43. Gill PS, McLaughlin T, Espina BM, Tulpule A, Louie S, Lunardi-Iskandar Y, Gallo RC. Phase I study of human chorionic gonadotropin given subcutaneously to patients with acquired immunodeficiency syndrome-related mucocutaneous Kaposi's sarcoma. J Natl Cancer Inst. 1997 Dec 03; 89(23):1797-802. PMID: 9392621.
      View in: PubMed
    44. Jie C, Tulpule A, Zheng T, Masood R, Espina B, Gill PS. Treatment of epidemic (AIDS-related) Kaposi's sarcoma. Curr Opin Oncol. 1997 Sep; 9(5):433-9. PMID: 9327221.
      View in: PubMed
    45. Levine AM, Tulpule A, Tessman D, Kaplan L, Giles F, Luskey BD, Scadden DT, Northfelt DW, Silverberg I, Wernz J, Espina B, Von Hoff D. Mitoguazone therapy in patients with refractory or relapsed AIDS-related lymphoma: results from a multicenter phase II trial. J Clin Oncol. 1997 Mar; 15(3):1094-103. PMID: 9060550.
      View in: PubMed
    46. Tulpule A, Joshi B, DeGuzman N, Espina BM, Mocharnuk R, Prakash O, Templeton D, Levine AM, Gill PS. Interleukin-4 in the treatment of AIDS-related Kaposi's sarcoma. Ann Oncol. 1997 Jan; 8(1):79-83. PMID: 9093711.
      View in: PubMed
    47. Gill PS, Lunardi-Ishkandar Y, Louie S, Tulpule A, Zheng T, Espina BM, Besnier JM, Hermans P, Levine AM, Bryant JL, Gallo RC. The effects of preparations of human chorionic gonadotropin on AIDS-related Kaposi's sarcoma. N Engl J Med. 1996 Oct 24; 335(17):1261-9. PMID: 8857005.
      View in: PubMed
    48. Levine AM, Tulpule A, Espina B, Boswell W, Buckley J, Rasheed S, Stain S, Parker J, Nathwani B, Gill PS. Low dose methotrexate, bleomycin, doxorubicin, cyclophosphamide, vincristine, and dexamethasone with zalcitabine in patients with acquired immunodeficiency syndrome-related lymphoma. Effect on human immunodeficiency virus and serum interleukin-6 levels over time. Cancer. 1996 Aug 01; 78(3):517-26. PMID: 8697399.
      View in: PubMed
    49. Gill PS, Espina BM, Muggia F, Cabriales S, Tulpule A, Esplin JA, Liebman HA, Forssen E, Ross ME, Levine AM. Phase I/II clinical and pharmacokinetic evaluation of liposomal daunorubicin. J Clin Oncol. 1995 Apr; 13(4):996-1003. PMID: 7707129.
      View in: PubMed
    50. Israel VK, Jiang C, Muggia FM, Tulpule A, Jeffers S, Leichman L, Morrow CP, Roman L, Leichman CG, Chan KK. Intraperitoneal 5-fluoro-2'-deoxyuridine (FUDR) and (S)-leucovorin for disease predominantly confined to the peritoneal cavity: a pharmacokinetic and toxicity study. Cancer Chemother Pharmacol. 1995; 37(1-2):32-8. PMID: 7497594.
      View in: PubMed
    51. Muggia FM, Tulpule A, Retzios A, Chen F, Jeffers S, Leichman CG, Leichman L, Spears CP, Chan KK. Intraperitoneal 5-fluoro-2'-deoxyuridine with escalating doses of leucovorin: pharmacology and clinical tolerance. Invest New Drugs. 1994; 12(3):197-206. PMID: 7896538.
      View in: PubMed
    52. Gill PS, Espina BM, Moudgil T, Kidane S, Esplin JA, Tulpule A, Levine AM. All-trans retinoic acid for the treatment of AIDS-related Kaposi's sarcoma: results of a pilot phase II study. Leukemia. 1994; 8 Suppl 3:S26-32. PMID: 7808021.
      View in: PubMed